Scientific article
English

The use of patch tests in the diagnosis of delayed hypersensitivity drug eruptions

Published in

International journal of dermatology, vol. 55, no. 11, p. 1219-1224

Publication date

2016-11

Abstract

Background: Adverse drug reactions (ADRs) are common. In the absence of a sufficiently sensitive and specific laboratory test, identification of the culprit drug remains a diagnostic challenge. Patch tests have recently been advocated as a means of detecting drug sensitivity.

Objective: To further elucidate the usefulness of patch tests in revealing the causative drugs of cutaneous ADRs (CADRs).

Materials and methods: We conducted a non-blinded, prospective, controlled clinical trial. Twenty-five patients with a history of CADRs were patch tested, and 25 healthy subjects who had never experienced CADRs served as controls.

Results: A morbilliform eruption was the most frequent skin reaction. Patch tests were positive in eight of the 25 patients with CADR (32%). Specifically, five of the 13 patients with morbilliform drug eruption (38.4%) tested positive, as did one of the four patients with erythema multiforme/Stevens-Johnson syndrome (25%), and one of the two patients with the drug reaction with eosinophilia and systemic symptoms syndrome. Antibiotics and anticonvulsants resulted in positive patch tests most often. Patch test sensitivity was 32%, specificity was 92%, and negative and positive predictive values were 57.5% and 80%, respectively. Significant correlation was found between the patch test result and the clinical probability of a CADR according to the imputability score of the drug.

Conclusions: Patch testing for drugs causing ADRs shows high specificity rates even though the sensitivity is low. Such tests may therefore be useful in supporting the diagnosis of delayed-type CADRs, particularly when antibiotics or anticonvulsants are involved and the cutaneous reaction is a morbilliform rash.

Keywords

  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / immunology
  • Anticonvulsants / adverse effects
  • Anticonvulsants / immunology
  • Drug Eruptions / diagnosis
  • Drug Eruptions / etiology
  • Drug Hypersensitivity Syndrome / diagnosis
  • Drug Hypersensitivity Syndrome / etiology
  • Female
  • Humans
  • Hypersensitivity, Delayed / chemically induced
  • Hypersensitivity, Delayed / diagnosis
  • Male
  • Middle Aged
  • Patch Tests
  • Predictive Value of Tests
  • Prospective Studies
  • Stevens-Johnson Syndrome / diagnosis
  • Stevens-Johnson Syndrome / etiology
  • Young Adult

UNIGE affiliation entities

Not a UNIGE publication

Citation (ISO format)

HASSOUN-KHEIR, Nasreen, BERGMAN, Reuven, WELTFRIEND, Sara. The use of patch tests in the diagnosis of delayed hypersensitivity drug eruptions. In: International journal of dermatology, 2016, vol. 55, n° 11, p. 1219–1224. doi: 10.1111/ijd.13306

Main files (1)

Article (Published version)

Identifiers

Journal ISSN

0011-9059
39views
0downloads

Technical informations

Creation

06/02/2025 14:47:15

First validation

05/03/2025 13:51:01

Update

05/03/2025 13:51:01

Status update

05/03/2025 13:51:01

Last indexation

05/03/2025 13:51:03
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated